Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.
about
Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.Global diffusion tensor imaging derived metrics differentiate glioblastoma multiforme vs. normal brains by using discriminant analysis: introduction of a novel whole-brain approach.The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.A radiosensitivity gene signature in predicting glioma prognostic via EMT pathwayMicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.Distance-based classifiers as potential diagnostic and prediction tools for human diseases.High metallothionein predicts poor survival in glioblastoma multiforme.Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed GlioblastomaTextural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.Revisiting the Relationship Between Ethnicity and Outcome in Glioblastoma Patients.Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.AR-A 014418 Used against GSK3beta Downregulates Expression of hnRNPA1 and SF2/ASF Splicing Factors.An advanced glioma cell invasion assay based on organotypic brain slice cultures.Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
P2860
Q27853219-2EE9D9AE-B07F-4DF7-ADDF-C3ACE4B7A3D8Q33831921-1AC61ADD-0C17-4A17-90CC-97DE1060C4E6Q34061985-9CA406EA-4649-4872-BEBB-F05546582313Q34103984-3C520BEF-2D29-4A97-957D-B53245A92FA4Q34409620-DCE2C66B-EBAA-4AE2-81FA-6525EAAC8482Q34943946-66491D12-46B5-4E5E-9676-86F0DAD8B7C1Q35538892-96EB2555-0807-47B7-88EC-11EF063AD867Q35817939-E1A1960C-F634-4FAA-AA07-22BC11C004A7Q36424068-DA406323-5BE8-41F0-987D-CAF049991105Q38980180-8AC93E7D-C2BC-457E-A434-C63650A1DEA0Q39123473-465D6BEB-63AE-495B-8114-5680CADE2E30Q39273311-E190969A-B13C-44A2-9BDA-92131B3D9F89Q39488671-397575F3-BB4F-4C43-B175-50982C1C1309Q41811698-67A5264E-3397-4C0E-BB32-376D6ED89AA8Q47834010-8C769249-D5E8-49F4-8118-FA6D45F49874Q48718486-C67FBCA9-5657-4312-869E-C0EF929C9E6AQ55460933-29F48DD0-9B67-4DA6-BD20-A71B20C05ED8
P2860
Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predictors of long-term surviv ...... from the last quarter century.
@en
type
label
Predictors of long-term surviv ...... from the last quarter century.
@en
prefLabel
Predictors of long-term surviv ...... from the last quarter century.
@en
P2093
P2860
P1433
P1476
Predictors of long-term surviv ...... from the last quarter century.
@en
P2093
Amade Bregy
Ashish H Shah
Brian M Snelling
Karthik Madhavan
Nauman S Chaudhry
Nicholas Ferraro
P2860
P304
P356
10.3109/07357907.2013.789899
P577
2013-04-24T00:00:00Z